查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1698444

心臟定位市场：2025-2030 年全球预测

Global Cardiac Mapping Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 147 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计到 2025 年心臟定位市场价值将达到 1,423,559,000 美元，到 2030 年预计将达到 2,291,392,000 美元，复合年增长率为 9.99%。

心臟定位是电生理学 (EP) 的研究。心臟定位过程有助于识别心臟中不同类型的时间和空间分布。该系统还有助于准确识别不同部位的异常心律并进行射频心导管电气烧灼术治疗。全球心血管疾病盛行率的上升是预测期内推动该市场成长的主要因素。同样，心臟定位设备的技术进步也有望推动市场扩张。成功治疗心房颤动的新型有效技术为市场相关人员提供了宝贵的机会，以增强其市场竞争力并加速整体市场成长。

市场趋势：

  • 全球心血管疾病患者数量增加：心律不整、心臟病和冠状动脉疾病等心血管疾病的盛行率不断上升是心臟定位市场的主要驱动力。根据美国疾病管制与预防中心 (CDC) 的数据，2022 年记录的心血管疾病病例为 702,880 例，凸显了对先进心臟定位解决方案的需求日益增长。
  • 技术进步：医疗技术的创新提高了心臟定位系统的准确性和效率，从而推动了需求。
  • 改善医疗保健基础设施和政府政策：改善全球医疗保健基础设施和支持性政府政策是推动心臟定位系统发展和采用的关键因素。
  • 北美市场发展：预计预测期内北美将占据心臟定位市场的大部分份额。这是因为该地区拥有完善的医疗保健行业、优质的医疗服务以及较早采用先进的医疗设备。此外，美国等国家老年人口的增长以及心臟相关问题风险的增加也推动了对心臟定位系统的需求。

报告中介绍的主要企业包括 Biosense Webster, Inc.、Medtronic、Abbott、BIOTRONIK SE &Co KG、Acutus Medical、Boston Scientific Corporation、AMETEK Inc.、Catheter Precision Inc.、Medical Device Business Services, Inc. (Johnson&Johnson)、MicroPort Scientific Corporation.

本报告的主要优点

  • 深刻分析：获得涵盖主要地区和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他子区隔。
  • 竞争格局：了解全球主要企业所采用的策略策略，并了解正确策略带来的潜在市场渗透。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响市场的未来发展。
  • 可行的建议：利用洞察力进行策略决策，在动态环境中开闢新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问公司、中小企业和大型企业都有益且具有成本效益。

它有什么用途？

产业和市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

  • 2022 年至 2024 年的历史数据和 2025 年至 2030 年的预测数据
  • 成长机会、挑战、供应链前景、法律规范与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 收益成长和预测分析（包括国家在内的细分市场和地区）
  • 公司概况（策略、产品、财务资讯、主要趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 研究范围
  • 市场区隔

第三章 商业景气

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

第五章全球心臟定位市场（按产品）

  • 介绍
  • 电生理消融导管
  • EP实验室设备
  • EP诊断导管
  • 存取装置

第六章全球心臟定位市场适应症

  • 介绍
  • 心房颤动
  • 心房扑动
  • 房室结迴旋性心搏过速
  • 沃尔夫-巴金森-怀特氏症候群

第七章全球心臟定位市场（按最终用户）

  • 介绍
  • 医院和诊所
  • 诊断中心

第八章全球心臟定位市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 台湾
    • 其他的

第九章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争仪錶板

第十章 公司简介

  • Biosense Webster, Inc.
  • Medtronic
  • Abbott
  • BIOTRONIK SE & Co. KG
  • Acutus Medical
  • Boston Scientific Corporation
  • AMETEK Inc.
  • Catheter Precision Inc.
  • Medical Device Business Services, Inc.（Johnson & Johnson）
  • MicroPort Scientific Corporation
  • Koninklijke Philips NV
  • Kardium Inc.

第十一章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061613782

The global cardiac mapping market is estimated at US$1,423.559 million in 2025 and is expected to grow at a CAGR of 9.99% to attain US$2,291.392 million in 2030.

Cardiac mapping is the study of electrophysiology or EP. The cardiac mapping process helps in identifying various types of temporal and spatial distribution in the heart. This system also helps in accurately recognizing various sites of abnormal rhythm and delivers radio-frequency catheter ablation therapy. The increasing global prevalence of cardiovascular diseases is the major factor propelling this market's growth during the forecasted timeline. Similarly, technological advancements in cardiac mapping devices are also estimated to propel market expansion. New and effective techniques for the successful treatment of atrial fibrillation are offering market players valuable opportunities to enhance their competitive position and accelerate overall market growth.

Market Trends:

  • Rising Global Cardiovascular Disease Cases: The increasing prevalence of cardiovascular diseases, such as arrhythmias, heart attacks, and coronary artery disease, is a key driver of the cardiac mapping market. According to the U.S. Centers for Disease Control and Prevention (CDC), there were 702,880 recorded cases of cardiovascular diseases in 2022, highlighting the growing demand for advanced cardiac mapping solutions.
  • Technological Advancements: Innovations in medical technology are enhancing the accuracy and efficiency of cardiac mapping systems, driving their demand. These advancements are making cardiac mapping more effective and accessible, contributing to market growth.
  • Improved Healthcare Infrastructure and Government Policies: Global improvements in healthcare infrastructure, along with supportive government policies, are significant factors boosting the development and adoption of cardiac mapping systems.
  • North America's Market Leadership: North America is expected to hold a substantial share of the cardiac mapping market during the forecast period. This is due to the region's well-established healthcare industry, availability of high-quality medical services, and early adoption of advanced medical devices. Additionally, the growing elderly population and increased risk of heart-related issues in countries like the U.S. are driving demand for cardiac mapping systems.

Some of the major players covered in this report include Biosense Webster, Inc., Medtronic, Abbott, BIOTRONIK SE & Co KG, Acutus Medical, Boston Scientific Corporation, AMETEK Inc., Catheter Precision Inc., Medical Device Business Services, Inc. (Johnson&Johnson), MicroPort Scientific Corporation, Koninklijke Philips N.V, and Kardium Inc. among others.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Global Cardiac Mapping Market is analyzed into the following segments:

By Product

  • EP Ablation Catheters
  • EP Laboratory Devices
  • EP Diagnostic Catheters
  • Access Devices

By Indication

  • Atrial Fibrillation
  • Atrial Flutter
  • Atrioventricular Nodal Re-entry Tachycardia
  • Wolff-Parkinson-White Syndrome

By End-User

  • Hospitals and Clinics
  • Diagnostic Centers

By Region

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CARDIAC MAPPING MARKET BY PRODUCT

  • 5.1. Introduction
  • 5.2. EP Ablation Catheters
  • 5.3. EP Laboratory Devices
  • 5.4. EP Diagnostic Catheters
  • 5.5. Access Devices

6. GLOBAL CARDIAC MAPPING MARKET BY INDICATION

  • 6.1. Introduction
  • 6.2. Atrial Fibrillation
  • 6.3. Atrial Flutter
  • 6.4. Atrioventricular Nodal Re-entry Tachycardia
  • 6.5. Wolff-Parkinson-White Syndrome

7. GLOBAL CARDIAC MAPPING MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals and Clinics
  • 7.3. Diagnostic Centers

8. GLOBAL CARDIAC MAPPING MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product
    • 8.2.2. By Indication
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Product
    • 8.3.2. By Indication
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Product
    • 8.4.2. By Indication
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Product
    • 8.5.2. By Indication
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Product
    • 8.6.2. By Indication
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Biosense Webster, Inc.
  • 10.2. Medtronic
  • 10.3. Abbott
  • 10.4. BIOTRONIK SE & Co. KG
  • 10.5. Acutus Medical
  • 10.6. Boston Scientific Corporation
  • 10.7. AMETEK Inc.
  • 10.8. Catheter Precision Inc.
  • 10.9. Medical Device Business Services, Inc. (Johnson & Johnson)
  • 10.10. MicroPort Scientific Corporation
  • 10.11. Koninklijke Philips N.V.
  • 10.12. Kardium Inc.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations